The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis-Reference-Cited by-同舟云学术

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis

Published:2019-04-17 Issue:1 Volume:12 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Zhang Guyu,Zhu Yimin,Liu Chongdong,Chao Guangming,Cui Ran,Zhang Zhenyu

Funder

National Natural Science Funds

Ministry of Science and Technology

Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-019-0509-1.pdf

Reference31 articles.

1. Siegel RL, Miller KD, PhD AJD. Cancer statistics, 2017. Ca A Cancer Journal for Clinicians. 2017;67(1).

2. Bijelic L, Jonson A, Sugarbaker PH. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Annals of Onco Off J Eur Soc Med Oncol. 2007;18(12):1943.

3. Tewari D, Java JJ, Salani R, Armstrong DK, Markman M, Herzog T, Monk BJ, Chan JK. Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(13):1460–6.

4. Wright AA, Cronin A, Milne DE, Bookman MA, Burger RA, Cohn DE, Cristea MC, Griggs JJ, Keating NL, Levenback CF. Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian Cancer. J Clin Onco Off J Am Soc Clin Oncol. 2015;33(26):2841–7.

5. Gonzalez-Moreno S, Gonzalez-Bayon LA, Ortega-Perez G. Hyperthermic intraperitoneal chemotherapy: rationale and technique. World journal of gastrointestinal oncology. 2010;2(2):68–75. https://doi.org/10.4251/wjgo.v2.i2.68 .

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperthermic intraperitoneal chemotherapy (HIPEC) vs. postoperative intraperitoneal (IP) chemotherapy – Impact on health-related quality of life in primary ovarian cancer patients after cytoreductive surgery;Surgical Oncology Insight;2024-09

2. Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-07-08

3. Consenso de expertos basado en la evidencia: perfilamiento y manejo del carcinoma epitelial de ovario de alto grado avanzado;Revista Colombiana de Obstetricia y Ginecología;2024-06-14

4. Discrepancy between recommendations regarding hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management: a narrative review;Chinese Clinical Oncology;2024-06

5. Interdisziplinär ausgerichtetes Operationsspektrum in Kooperation von Viszeralchirurgie und Gynäkologie;Die Chirurgie;2024-01-31